Drug Profile
IT 139 companion diagnostic - Intezyne
Latest Information Update: 28 Feb 2019
Price :
$50
*
At a glance
- Originator Intezyne
- Class Diagnostic agents; Exosome therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for preclinical development in Solid-tumours(Diagnosis) in European Union
- 28 Feb 2019 No recent reports of development identified for preclinical development in Solid-tumours(Diagnosis) in USA
- 01 Aug 2018 Exosome Diagnostics has been acquired by Bio-Techne